Dose-dense chemotherapy enables elimination of RT for majority of low-risk pediatric Hodgkin lymphoma: PHC study HOD08. Flerlage JE, Feraco AM MD, MMSc, Zhou Y, Zheng Y MS, et al. Blood 2026 Jan 13:blood.2025029535. doi: 10.1182/blood.2025029535.

Read + Share

Amedeo Smart

Independent Medical Education

Flerlage JE, Feraco AM MD, MMSc, Zhou Y, Zheng Y MS, et al. Dose-dense chemotherapy enables elimination of RT for majority of low-risk pediatric Hodgkin lymphoma: PHC study HOD08. Blood 2026 Jan 13:blood.2025029535. doi: 10.1182/blood.2025029535.
PMID: 41529162